Latest Guanidines Stories
Muscle and Strength, an industry leader in Creatine Supplements, receives a best-in-class 5-star rating from TopConsumerReviews.com. Overland Park, KS (PRWEB)
A large study from Africa, published in this week's PLoS Medicine, has found that in a direct comparison, three types of new, fast-acting antimalarial artemisinin-based combination therapy drugs (ACTs), which comprise artemisinin derivatives in combination with a partner antimalarial drug, AL (artesunate–mefloquine), ASAQ (artesunate–amodiaquine) and DHAPQ (dihydroartemisinin–piperaquine) are all effective for treating children with uncomplicated malaria.
A research team at the Shanghai Jiao Tong University in China has conducted a meta-analysis demonstrating that metformin treatment also appears to be associated with significantly lower risk of
SAN FRANCISCO, Aug. 16, 2011 /PRNewswire/ -- Practice Fusion's Research Division released today the second annual Prescription Index of the 20 most commonly prescribed medications by specialty among physicians using the company's Electronic Medical Record (EMR) system.
SAN MARCOS, Calif., Aug. 3, 2011 /PRNewswire/ -- Natural Alternatives International, Inc.
A new study shows a dietary supplement containing an amino acid and antioxidant vitamins may protect pregnant women from preeclampsia.
A dietary supplement containing an amino acid and antioxidant vitamins, given to pregnant women at high risk of pre-eclampsia, can reduce the occurrence of the disease.
SAN DIEGO, April 8, 2011 /PRNewswire/ -- Polaris Group (Polaris) announced today that data from preclinical studies suggest ADI-PEG 20, the Company's pegylated arginine deiminase therapeutic, may be effective in treating acute myeloid leukemia (AML), glioblastoma multiforme (GBM) and bladder cancer.
New research suggests that several commonly prescribed drugs for type 2 diabetes may not be as effective at preventing death and cardiovascular diseases, such as heart attacks and stroke, as the oral anti-diabetic drug, metformin.
Research led by Warwick Medical School at the University of Warwick has found that Metformin, a drug treatment used to treat diabetes and also women with Polycystic Ovary syndrome (PCOS), may potentially provide protection against endometrial cancer.